High Ingredient Prices Increase Supply Chain Risks – FDA Compliance Exec
This article was originally published in The Tan Sheet
Executive SummaryRising ingredient prices should raise red flags for dietary supplement firms that lack supply chain oversight, FDA compliance official Deborah Autor said
You may also be interested in...
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.